Pediatric Diabetes

The 2022 International Society for Pediatric and Adolescent Diabetes guidelines include updates on insulin delivery, psychological care and nutritional management for children, adolescents and young people with diabetes.

Researchers hypothesize that the number of youths in the U.S. with diabetes is likely to substantially increase in future decades, highlighting the need for diabetes prevention, according to estimates published in Diabetes Care.

Obesity was not a universal phenotype among children with type 2 diabetes, despite being an important risk factor, according to a systematic review and meta-analysis published in JAMA Network Open.

For children and young adults with type 1 diabetes, comorbidities such as obesity and asthma increased the risk for COVID-19 hospitalization, according to study results published in Pediatric Diabetes.

A phase 3 trial of empagliflozin demonstrated statistically significant HbA1c reduction among children and adolescents aged 10 to 17 years with type 2 diabetes, according to a press release from Eli Lilly.

Type 2 diabetes rates and associated number of years lost due to poor health, disability or early death increased substantially among adolescents and young adults from 1990 to 2019, particularly in low- and low-middle income countries.

Children, adolescents and young adults with Down syndrome have higher incidence rates of type 1 and type 2 diabetes compared with matched controls without Down syndrome, according to a study published in Diabetes Care.

Use of continuous glucose monitoring among children and young adults with type 1 diabetes nearly doubled from 2017 to 2020 in the U.S. from 25% to 49% and was associated with lower HbA1c for users vs. non-users, according to registry data.

Adolescent girls with type 1 diabetes lost trabecular volumetric bone mineral density over 1 year compared with gains for girls without diabetes, with greater loss at higher HbA1c levels, according to a speaker.

Subcutaneous insulin therapy was associated with shorter hospital stay and lower cost vs. intravenous insulin infusion for the treatment of mild diabetic ketoacidosis for children with type 1 diabetes, according to study data.